Get started
Author

Yadriel Bracero

Observed name: Yadriel M. Bracero
ORCID: 0009-0002-6483-4867
Observed ORCID: 0009-0002-6483-4867
OpenAlex ID: A5093056913
An update on methods for detection of prognostic and predictive biomarkers in melanoma
2023 · Oluwaseyi Adeuyan, Emily R. Gordon, et al. · Frontiers in Cell and Developmental Biology · 19
PDF
Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer
2024 · Karie Runcie, Yadriel Bracero, et al. · The Oncologist · 16
PDF
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma
2025 · Thazin N. Aung, Matthew Liu, et al. · JAMA Network Open · 14
PDF
Pathomic immune biomarkers define recurrence risk in early-stage melanoma
2025 · Thazin Nwe Aung, Ajay Singh, et al. · The Oncologist · 3
PDF
Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients
2024 · Brian Ko, Kevin Tao, et al. · Melanoma Research · 1
Validation of melanoma immune profile (MIP) to predict RFS in stage II-III melanoma on adjuvant interferon trial (E1697).
2026 · Yvonne M. Saenger, Tianyun Jiang, et al. · Journal of Clinical Oncology
49 Complement system alterations in hepatocellular carcinoma (HCC): insights from mRNA-proteome integration and receptor blockade studies
2025 · Divya B Kenchappa, Ajay K Singh, et al. · Regular and Young Investigator Award Abstracts
PDF
Case Report: An unexpected case of tumor regression in blue nevus melanoma following COVID-19 infection
2025 · Yadriel Bracero, Emily Nghiem, et al. · Frontiers in Immunology
PDF
55 Dissecting patterns of expression of complement genes in hepatocellular cancer and their potential role in tumor progression
2024 · Ajay Singh, Divya Kenchappa, et al. · Regular and Young Investigator Award Abstracts
127 Digital pathology prognostic biomarkers- time for clinical application in melanoma
2024 · Yvonne Saenger, Chenxin Zhang, et al. · Regular and Young Investigator Award Abstracts
1245 Spatial distribution and abundance of tumor cells, T cells and macrophages correlate with recurrence of stage II and III melanoma
2024 · Suryansh Shukla, Chenxin Zhang, et al. · Regular and Young Investigator Award Abstracts
Abstract 1058: Immune biomarkers for recurrence in stage II and III melanoma to guide patient stratification
2024 · Gerardo A. Espinoza, Chenxin Zhang, et al. · Cancer Research
Works count: 12
Citation count: 53
H-index: 3
I10-index: 3
Year
Topic
Type